11. 1 November 2012 - 31 October 2013. (December 2018) Journal: Multiple sclerosis Issue: Volume 24:Number 14(2018) Page Start: NP1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. 1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS. (17th June 2012) Authors: Cameron, Michelle; Wagner, Joanne; Zackowski, Kathleen; Spain, Rebecca Other Names: Patti Francesco Academic Editor. Journal: Multiple sclerosis international Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. 2017 McDonald MS diagnostic criteria: Evidence-based revisions. (February 2018) Authors: Carroll, William M Journal: Multiple sclerosis Issue: Volume 24:Number 2(2018) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. 2018 Editors' commentary. (October 2018) Authors: Thompson, Alan; Antel, Jack; Carroll, William M; Geurts, Jeroen JG Journal: Multiple sclerosis Issue: Volume 24:Number 11(2018) Page Start: 1394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. 22nd Annual RIMS Conference 2017. (May 2017) Journal: Multiple sclerosis Issue: Volume 23:Number 6(2017) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. 4-Aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Commentary. (October 2020) Authors: Hartung, Hans-Peter; Dietrich, Michael; Albrecht, Philipp Journal: Multiple sclerosis Issue: Volume 26:Number 11(2020) Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – No. (October 2020) Authors: Göbel, Kerstin; Wiendl, Heinz Journal: Multiple sclerosis Issue: Volume 26:Number 11(2020) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes. (October 2020) Authors: Strijbis, Eva MM; Nij Bijvank, Jenny A; Killestein, Joep Journal: Multiple sclerosis Issue: Volume 26:Number 11(2020) Page Start: 1309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. 6th Pactrims Invited Lecture. (June 2014) Journal: Multiple sclerosis Issue: Volume 20:Number 7(2014) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. 7 Tesla MRI will soon be helpful to guide clinical practice in multiple sclerosis centers – Commentary. (March 2021) Authors: Sati, Pascal; Reich, Daniel S Journal: Multiple sclerosis Issue: Volume 27:Number 3(2021) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗